Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 4/2012

01-04-2012 | Clinical Research

Investigation of Antidepressant Medication Usage after Bariatric Surgery

Authors: Julie L. Cunningham, Cory C. Merrell, Michael Sarr, Kristin J. Somers, Donald McAlpine, Michael Reese, Susanna R. Stevens, Matthew M. Clark

Published in: Obesity Surgery | Issue 4/2012

Login to get access

Abstract

Background

Many patients seeking bariatric surgery have a history of mood disorders and are actively prescribed antidepressants. While extensive documentation exists on the impact of weight loss surgery on reductions in cardiac, diabetic, and hypertensive medications, little is known about the impact of bariatric surgery on the use of antidepressant medications.

Methods

A retrospective study of 439 patients who had undergone Roux-en-Y gastric bypass (RYGB) from January 2001 to November 2004 was examined for postoperative changes in the use of antidepressant medications.

Results

After RYGB, 23% of the patients had an increase in their antidepressant use, 40% continued to require the same antidepressant, 18% had a change in antidepressant medication, and only 16% had a decrease or discontinued their antidepressant.

Conclusion

Unlike most medications, antidepressant usage did not decrease in the majority of patients after RYGB. These results highlight the prevalence of antidepressant prescription use in patients before and after RYGB and support the need for the careful monitoring of depressive symptoms.
Literature
1.
Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909–17.PubMedCrossRef
2.
3.
Collazo-Clavell ML, Clark MM, McAlpine DE, et al. Assessment and preparation of patients for bariatric surgery. Mayo Clin Proc. 2006;81:S11–7.PubMed
4.
Halmi A. KA, Long M, Stunkard AJ et al. Psychiatric diagnosis of morbidly obese gastric bypass patients. Am J Psychiatry. 1980;137:470–2.PubMed
5.
Black DW, Goldstein RB, Mason EE. Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients. Am J Psychiatry. 1992;149:227–34.PubMed
6.
Rosik CH. Psychiatric symptoms among prospective bariatric surgery patients: rates of prevalence and their relation to social desirability, pursuit of surgery, and follow-up attendance. Obes Surg. 2005;15:677–83.PubMedCrossRef
7.
Sarwer DB, Cohn NI, Gibbons LM, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg. 2004;14:1148–56.PubMedCrossRef
8.
Powers PS, Rosemurgy A, Boyd F, et al. Outcome of gastric restriction procedures: weight, psychiatric diagnoses, and satisfaction. Obes Surg. 1997;7:471–7.PubMedCrossRef
9.
Clark MM, Niaura R, King TK, et al. Depression, smoking, activity level, and health status: pretreatment predictors of attrition in obesity treatment. Addict Behav. 1996;21:509–13.PubMedCrossRef
10.
Segal JB, Clark JM, Shore AD, et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg. 2009;19:1646–56.PubMedCrossRef
11.
Wadden TA, Sarwer DB, Womble LG, et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am. 2001;81:1001–24.PubMedCrossRef
12.
Batsis JA, Lopez-Jimenez F, Collazo-Clavell ML et al. Quality of life after bariatric surgery. Am J Med. 2009;122: 1055.e1-10.
13.
Zwaan M, Enderle J, Wagner S et al. Anxiety and depression in bariatric surgery patients: a prospective, follow-up study using structured clinical interviews. J Affect Disord 2011; in press.
14.
Hayden MJ, Dixon JB, Dixon ME, et al. Characterization of the improvement in depressive symptoms following bariatric surgery. Obes Surg. 2011;21:328–35.PubMedCrossRef
15.
Assimakopoulos K, Karaivazoglou K, Panayiotopoulos S, et al. Bariatric surgery is associated with reduced depressive symptoms and better sexual function in obese female patients: a one-year follow-up study. Obes Surg. 2011;21:362–66.PubMedCrossRef
16.
Clark MM, Hanna BK, Mai JL, et al. Sexual abuse survivors and psychiatric hospitalization after bariatric surgery. Obes Surg. 2007;17:465–9.PubMedCrossRef
17.
Potteiger CE, Paragi PR, Inverso NA, et al. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care area. Obes Surg. 2004;14:725–30.PubMedCrossRef
18.
Batsis JA, Romero-Corral A, Collazo-Clavell ML, et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83:897–907.PubMed
19.
Kendrick ML, Clark MM, Collazo-Clavell MD, et al. The multidisciplinary team in a bariatric surgery program. In: Buchwald H, Cowan Jr GSM, Pories WJ, editors. Surgical Management of Obesity. Philadelphia: Elsevier Science; 2006. p. 425–31.
20.
Krukowski RA, Friedman KE, Applegate KL. The utility of the Beck Depression Inventory in a bariatric surgery population. Obes Surg. 2010;20:426–31.PubMedCrossRef
21.
Hayden MJ, Dixon JB, Dixon ME, et al. Confirmatory factor analysis of the Beck Depression Inventory in obese individuals seeking surgery. Obes Surg. 2010;20:432–39.PubMedCrossRef
22.
Demyttenaere K, Jaspers L. Bupropion and SSRI-induced side effects. J Psychopharmacol. 2008;22:792–804.PubMedCrossRef
23.
Sussman N, Ginsberg DL, Bikoff J. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. J Clin Psychiatry. 2001;62:256–60.PubMedCrossRef
24.
Aronne LJ, Segal KR. Weight gain in the treatment of mood disorders. J Clin Psychiatry. 2003;64:22–9.PubMed
25.
Schwartz TL, Nihalani N, Jindal S, et al. Psychiatric medication-induced obesity: a review. Obes Rev. 2004;5:115–21.PubMedCrossRef
26.
Schwartz TL, Nihalani N, Virk S, et al. Psychiatric medication-induced obesity: treatment options. Obes Rev. 2004;5:233–8.PubMedCrossRef
27.
Vanina Y, Podolskaya A, Sedky K, et al. Body weight changes associated with psychopharmacology. Psychiatr Serv. 2002;53:842–7.PubMedCrossRef
28.
Virk S, Schwartz TL, Jindal S, et al. Psychiatric medication induced obesity: an aetiologic review. Obes Rev. 2004;5:167–70.PubMedCrossRef
29.
Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11:41–50.PubMedCrossRef
30.
Seaman JS, Bowers SP, Dixon MS, et al. Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model. Psychosomatics. 2005;46:250–3.PubMedCrossRef
31.
Sarwer DB, Faulconbridge LF, Steffen KF, et al. Changes in the gastrointestinal tract and body weight can alter drug absorption. Current Psych. 2011;10:19–29.
32.
McAlpine DE. How to adjust drug dosing after bariatric surgery. Current Psych. 2006;5:27–8.
33.
Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm. 2006;63:1852–7.PubMedCrossRef
34.
American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157:1–45.
Metadata
Title
Investigation of Antidepressant Medication Usage after Bariatric Surgery
Authors
Julie L. Cunningham
Cory C. Merrell
Michael Sarr
Kristin J. Somers
Donald McAlpine
Michael Reese
Susanna R. Stevens
Matthew M. Clark
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 4/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-011-0517-8

Other articles of this Issue 4/2012

Obesity Surgery 4/2012 Go to the issue

Clinical Research

Laparoscopic Sleeve Gastrectomy: a First Step for Rapid Weight Loss in Morbidly Obese Patients Requiring a Second Non-Bariatric Procedure

Clinical Research

Prediction of Whole-Body and Segmental Body Composition by Bioelectrical Impedance in Morbidly Obese Subjects

Clinical Research

The Influence of Overweight/Obesity on Patient-Perceived Physical Functioning and Health-Related Quality of Life After Primary Total Hip Arthroplasty

Clinical Research

An Integrated Therapy Concept for Reduction of Postoperative Complications After Resection of a Panniculus Morbidus

Review

Examining the Link Between Bariatric Surgery, Bone Loss, and Osteoporosis: a Review of Bone Density Studies

Clinical Research

Shared Medical Appointments for Bariatric Surgery Follow-up: a Patient Satisfaction Questionnaire